SEARCH

SEARCH BY CITATION

References

  • 1
    Knaus WA, Wagner DP, Draper EA et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100: 16191636.
  • 2
    Al-Hasan MN, Wilson JW, Lahr BD et al. Beta-lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gram-negative bacilli. Antimicrob Agents Chemother 2009; 53: 13861394.
  • 3
    Korvick JA, Bryan CS, Farber B et al. Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy. Antimicrob Agents Chemother 1992; 36: 26392644.
  • 4
    Paterson DL, Ko WC, Von Gottberg A et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial infections. Ann Intern Med 2004; 140: 2632.
  • 5
    Rhee JY, Kwon KT, Ki HK et al. Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis: a comparison of the Pitt bacteremia score and the Acute Physiology and Chronic Health Evaluation II scoring systems. Shock 2009; 31: 146150.
  • 6
    Pedersen G, Schonheyder HC, Sorensen HT. Source of infection and other factors associated with case fatality in community-acquired bacteremia—a Danish population-based cohort study from 1992 to 1997. Clin Microbiol Infect 2003; 9: 793802.
  • 7
    Kang CI, Kim SH, Park WB et al. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 2005; 49: 760766.
  • 8
    Cagatay AA, Ozcan PE, Gulec L et al. Risk factors for mortality of nosocomial bacteraemia in intensive care units. Med Princ Pract 2007; 16: 187192.
  • 9
    Chow JW, Yu VL. Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents 1999; 11: 712.
  • 10
    Pedersen G, Schonheyder HC, Sorensen HT. Antibiotic therapy and outcome of monomicrobial gram-negative bacteraemia: a 3-year population-based study. Scand J Infect Dis 1997; 29: 601606.
  • 11
    Laupland KB, Gregson DB, Church DL, Ross T, Pitout JD. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region. Clin Microbiol Infect 2008; 14: 10411047.
  • 12
    Cheong HS, Lee JA, Kang CI et al. Risk factors for mortality and clinical implications of catheter-related infections in patients with bacteraemia caused by Stenotrophomonas maltophilia. Int J Antimicrob Agents 2008; 32: 538540.
  • 13
    Lai CH, Chi CY, Chen HP et al. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia. J Microbiol Immunol Infect 2004; 37: 350358.
  • 14
    Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128140.
  • 15
    Harrell FE Jr. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York, NY: Springer, 2001.
  • 16
    Al-Hasan MN, Wilson JW, Lahr BD, Eckel-Passow JE, Baddour LM. Incidence of Pseudomonas aeruginosa bacteremia: a population-based study. Am J Med 2008; 121: 702708.
  • 17
    Mermel LA, Allon M, Bouza E et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49: 145.
  • 18
    Meatherall BL, Gregson D, Ross T, Pitout JD, Laupland KB. Incidence, risk factors, and outcomes of Klebsiella pneumoniae bacteremia. Am J Med 2009; 122: 866873.
  • 19
    Paez JI, Costa SF. Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review. J Hosp Infect 2008; 70: 101108.
  • 20
    Chen SY, Tsai CL, Lin CH et al. Impact of liver cirrhosis on mortality in patients with community-acquired bacteremia. Diagn Microbiol Infect Dis 2009; 64: 124130.
  • 21
    Kang CI, Song JH, Chung DR et al. Liver cirrhosis as a risk factor for mortality in a national cohort of patients with bacteremia. J Infect 2011; 63: 336343.
  • 22
    Chang TY, Lee CH, Liu JW. Clinical characteristics and risk factors for fatality in patients with bloodstream infections caused by glucose non-fermenting gram-negative bacilli. J Microbiol Immunol Infect 2010; 43: 233239.
  • 23
    Christou L, Pappas G, Falagas ME. Bacterial infection-related morbidity and mortality in cirrhosis. Am J Gastroenterol 2007; 102: 15101517.
    Direct Link:
  • 24
    Kumar A, Roberts D, Wood KE et al.Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34: 15891596.
  • 25
    Rodriguez-Bano J, de Cueto M, Retamar P, Galvez-Acebal J. Current management of bloodstream infections. Expert Rev Anti Infect Ther 2010; 8: 815829.
  • 26
    Al-Hasan MN, Eckel-Passow JE, Baddour LM. Influence of referral bias on the clinical characteristics of patients with Gram-negative bloodstream infection. Epidemiol Infect 2011; 139: 17501756.
  • 27
    Al-Hasan MN, Eckel-Passow JE, Baddour LM. Recurrent gram-negative bloodstream infection: a 10-year population-based cohort study. J Infect 2010; 61: 2833.
  • 28
    Leibovici L, Paul M, Poznanski O et al. Monotherapy versus beta-lactam–aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study. Antimicrob Agents Chemother 1997; 41: 11271133.